Nicox: Business Update and 2016 Financial Results Mar 31, 2017 01:31AM
Nicox resubmits AC-170 (ZERVIATE) NDA to the U.S. FDA Mar 9, 2017 01:31AM
Nicox to participate at two upcoming investor conferences Mar 1, 2017 11:45AM
Nicox announces the presentation of NCX 667 scientific data at AOPT 2017 Feb 21, 2017 03:50AM
Nicox announces the presentation of NCX 667 scientific data at AOPT 2017 Feb 21, 2017 03:38AM


Feb 9, 2017 11:46AM Nicox to present at the 6th Annual LEERINK Partners Global Healthcare Conference
Jan 24, 2017 01:34AM Nicox provides clinical and regulatory update for NCX 470 for IOP lowering
Jan 5, 2017 01:34AM Nicox provides clinical and regulatory update for NCX 4251 in blepharitis
Apr 19, 2016 02:52AM Nicox submits New Drug Application for AC-170 to U.S. FDA
Apr 6, 2016 04:05AM Nicox to present at the 15th Annual Needham Healthcare Conference
Feb 25, 2016 01:34AM Nicox reports strong revenue growth in 2015 and provides corporate update
Feb 3, 2016 04:04AM Nicox to present at the 18th Annual BIO CEO & Investor Conference
Jan 29, 2016 01:39AM Nicox out-licenses OTC asset AC 120 to Ora, Inc.
Mar 30, 2015 01:40AM Nicox 2014 Financial Results and Business Update